Maravai LifeSciences Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary

Maravai Lifesciences Holdings

08/11/2024 05:07

* Maravai LifeSciences Holdings Inc  MRVI.OQ  reported a
quarterly
adjusted loss of 2 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of -1 cents.  The mean expectation of
thirteen analysts for the quarter was for a loss of one cent per
share. Wall Street expected results to range from -2 cents to 2
cents per share.
    * Revenue fell 2.5% to $65.20 million from a year ago;
analysts
expected $67.56 million. 
    * Maravai LifeSciences Holdings Inc's reported EPS for the
quarter
was a loss of 70 cents​.
    * The company reported a quarterly loss of $99.04 million.
    * Maravai LifeSciences Holdings Inc shares had fallen
by 3.4% this
quarter and gained 22.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 31.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is 10.00 
This summary was machine generated from LSEG data November 8 at
05:07 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.01          -0.02          Missed
 Jun. 30 2024      0.00           0.00           Met
 Mar. 31 2024      -0.03          -0.02          Beat
 Dec. 31 2023      -0.01          0.01           Beat